Regulations, liability, safety, and economics related to compounding.
Extemporaneous compounding is a means to tailor a medication to an individual patient's needs and may be required when no commercial product exists to meet that need.
APA
Campbell EH, Elston DM, et al. (2020). Regulations, liability, safety, and economics related to compounding.. Journal of the American Academy of Dermatology, 83(1), 184-188. https://doi.org/10.1016/j.jaad.2019.11.061
MLA
Campbell EH, et al.. "Regulations, liability, safety, and economics related to compounding.." Journal of the American Academy of Dermatology, vol. 83, no. 1, 2020, pp. 184-188.
PMID
31821858
Abstract
Extemporaneous compounding is a means to tailor a medication to an individual patient's needs and may be required when no commercial product exists to meet that need. Compounded products range from buffered lidocaine to topical creams and ointments. Recent heightened regulations have made compounding more challenging for dermatologists and prompted this review of regulations, liability, and safety related to compounding. With this information, providers may minimize liability and maximize safety while caring for their patients.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 약물 | lidocaine
|
리도카인 | dict | 1 |
MeSH Terms
Drug Compounding; Drug-Related Side Effects and Adverse Reactions; Humans; Technology, Pharmaceutical; United States; United States Food and Drug Administration
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative effects of pharmacological interventions in the prophylactic treatment of tension-type headache: systematic review and network meta-analysis.
- Clinical safety of a low-modification hyaluronic acid filler (MoD 2%) for facial rejuvenation.
- Fat harvesting protocol for enhanced stem cell viability - pilot study.
- Medical management of refractory trigeminal neuralgia.